39891-08-2

Usage

Uses

Used in Pharmaceutical Industry:
(5-BROMO-PYRIDIN-3-YL)-ACETONITRILE is used as a building block for the synthesis of pharmaceuticals, contributing to the development of new drugs and therapeutic agents. Its unique chemical structure allows for the creation of a wide range of medicinal compounds with potential applications in treating various diseases and conditions.
Used in Agrochemical Industry:
In the agrochemical sector, (5-BROMO-PYRIDIN-3-YL)-ACETONITRILE is utilized as a key intermediate in the production of agrochemicals. Its reactivity and properties enable the synthesis of compounds that can be used in the development of pesticides, herbicides, and other agricultural chemicals to enhance crop protection and yield.
Used in Organic Chemistry Research:
(5-BROMO-PYRIDIN-3-YL)-ACETONITRILE serves as an important intermediate in organic chemistry research, where it is employed in the synthesis of various organic compounds. Its unique structure allows for further functionalization and modification, facilitating the exploration of new chemical reactions and the discovery of novel compounds with potential applications in various fields.
Used in Chemical Product Manufacturing:
As an intermediate in the production of various chemical products, (5-BROMO-PYRIDIN-3-YL)-ACETONITRILE plays a crucial role in the manufacturing process. Its presence in the synthesis of these products contributes to the development of new materials and compounds with diverse applications across different industries.

InChI:InChI=1/C7H5BrN2/c8-7-3-6(1-2-9)4-10-5-7/h3-5H,1H2

Upstream product

• 37669-64-0 (5-bromopyridin-3-yl)methanol 
• 20826-04-4 5-bromo-3-pyridinecarboxylic acid 
• 773837-37-9 sodium cyanide 
• 39741-46-3 3-bromo-5-(chloromethyl)-pyridine hydrochloride 
• 120277-69-2 5-bromo-pyridin-3-ylmethyl chloride 

Downstream Products

• 1257432-08-8 2-(5-bromo-pyridin-3-yl)-2-methyl-propionitrile 
• 847375-33-1 (5-bromo-pyridin-3-yl)-acetic acid ethyl ester 
• 1272355-37-9 1-(5-(5-phenyl-4-(pyridin-2-ylmethylamino)quinazolin-2-yl)pyridin-3-yl)cyclopropanecarbonitrile 
• 1272357-15-9 2-(5-(5-phenyl-4-(pyridin-2-ylmethylamino)quinazolin-2-yl)pyridin-3-yl)propanamide 
• 1272357-16-0 2-(5-(5-phenyl-4-(pyridin-2-ylmethylamino)quinazolin-2-yl)pyridin-3-yl)propanamide 
• 1272355-30-2 2-(5-(5-phenyl-4-(pyridin-2-ylmethylamino)quinazolin-2-yl)pyridin-3-yl)propanamide 
• 1272357-14-8 2-(5-(5-phenyl-4-(pyridin-2-ylmethylamino)quinazolin-2-yl)pyridin-3-yl)propanoic acid 
• 1272357-13-7 2-(5-(5-phenyl-4-(pyridin-2-ylmethylamino)quinazolin-2-yl)pyridin-3-yl)propanenitrile 
• 1272355-11-9 2-(5-(5-phenyl-4-(pyridin-2-ylmethylamino)quinazolin-2-yl)pyridin-3-yl)acetamide 
• 1272355-08-4 2-(5-(5-phenyl-4-(pyridin-2-ylmethylamino)quinazolin-2-yl)pyridin-3-yl)acetonitrile 

Relevant academic research and scientific papers

Novel 2,4-disubstituted pyrimidines as potent, selective, and cell-permeable inhibitors of neuronal nitric oxide synthase

Selective inhibition of neuronal nitric oxide synthase (nNOS) is an important therapeutic approach to target neurodegenerative disorders. However, the majority of the nNOS inhibitors developed are arginine mimetics and, therefore, suffer from poor bioavai

ALDOSTERONE SYNTHASE INHIBITORS

This invention relates to tricyclic triazole analogues of the formula I or their pharmaceutically acceptable salts, wherein the variable are defined herein. The inventive compounds selectively inhibit aldosterone synthetase. This invention also provides for pharmaceutical compositions comprising the compounds of Formula I or their salts as well as to methods for the treatment, amelioration or prevention of conditions that could be treated by inhibiting aldosterone synthetase.

QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS

A compound of formula (I) wherein A, X, Y, Z, R1 and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.

1H-IMIDAZO[4, 5-c]QUINOLINONE COMPOUNDS, USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASES

The invention relates to the use of 1 H-imidazo[4,5-c]quinolinone compounds and salts thereof in the treatment of protein and/or lipid kinase dependent diseases and for the manufacture of pharmaceutical preparations for the treatment of said diseases; 1 H-imidazo[4,5-c]quinolinone compounds for use in the treatment of protein and/or lipid kinase dependent diseases; a method of treatment against said diseases, comprising administering the 1 H-imidazo[4,5-c]quinolinone compounds to a warm-blooded animal, especially a human; pharmaceutical preparations comprising an 1 H-imidazo[4,5-c]quinolinone compounds, especially for the treatment of a protein and/or lipid kinase dependent disease; novel 1 H-imidazo[4,5-c]quinolinone compounds; and a process for the preparation of the novel 1 H-imidazo[4,5-c]quinolinone compounds.